Cancer Survival Toolbox, Audiotapes for Cancer Patients

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 9 No 1
Volume 9
Issue 1

SAN FRANCISCO-The Cancer Survival Toolbox is a set of self-learning audiotapes available in English and Spanish, designed for persons with cancer to help them develop skills needed to manage their cancer experience.

SAN FRANCISCO—The Cancer Survival Toolbox is a set of self-learning audiotapes available in English and Spanish, designed for persons with cancer to help them develop skills needed to manage their cancer experience.

The six skills taught in the tapes are self-advocacy, communication, information seeking, decision making, problem solving, and negotiation. Two new modules were introduced last year: “Finding Ways to Pay for Care” and “Topics for Older Persons.”

The program was developed by the National Coalition for Cancer Survivorship (NCCS), Association of Oncology Social Work, and Oncology Nursing Society. The audiotapes are available free of charge by phone at 1-877-TOOLS-4-U

(1-877-866-5748) or at the NCCS website www.cansearch.org/programs/toolbox.htm. The Toolbox is made possible through a grant from Genentech, Inc.

Articles in this issue
New Strategies for Treating Ovarian Cancer
Researchers See More Effective Lung Cancer Screening, Therapy
Goserelin Reduces Breast Ca Recurrence in Younger Women
ODAC Recommends Approval of Targretin for Advanced CTCL
IOM Assessing Early Breast Cancer Detection Technologies
CRFA Honors Three With Its 1999 FrontLine Awards
Aromasin, New Hormonal Agent, Approved for Breast Cancer
LEDs Developed by NASA Used to Ablate Brain Tumors
Early Androgen Deprivation Beneficial
Higher-Dose RT May Improve Prostate Cancer Outcome
Learning How to Break Bad News to Patients
Multiple View Ultrasound Aids Breast Lesion Characterization and Biopsy Needle Tracking
Conference Informs Patients About Pancreatic Cancer Treatments
Taxotere Gets FDA OK for Use in NSCLC
NCI Seeks Toxicity Studies of Five Natural Substances

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Subscribe Now!
Recent Videos
6371178759112
Focused, high-dose radiotherapy doses may prolong survival and the interval to subsequent therapy for patients with advanced prostate cancer.
Data show increasing use of proton therapy overall but widening gaps in populations who have access to this treatment, says Curtiland Deville Jr., MD.
Related Content
Promoting Psychosocial Cancer Care on World Psycho-Oncology Day

Promoting Psychosocial Cancer Care on World Psycho-Oncology Day

Tim Cortese
April 9th 2025
Article

The International Psycho-Oncology Society announced the first ever WPOD on April 9, 2025, to bring more focus to psychosocial care in cancer therapy.

Experts from Sibley Memorial Hospital discuss how multidisciplinary work has enhanced outcomes such as survival and resource use at their institution.

Elevating the Quality of Cancer Care Via Cross-Department Collaboration

Rachit Kumar, MD;Michael J. Pishvaian, MD, PhD;Nina D. Wagner-Johnston, MD;Valerie Lee, MD;Armine K. Smith, MD;Pouneh Razavi, MD;Curtiland Deville Jr., MD
April 7th 2025
Podcast

Experts from Sibley Memorial Hospital discuss how multidisciplinary work has enhanced outcomes such as survival and resource use at their institution.

Combining durvalumab with chemotherapy produced a good safety profile without increasing surgical risk in the phase 2 iNDUCT-GETUG V08 trial.

Durvalumab Combo Shows Encouraging Preliminary Data in High-Risk UTUC

Russ Conroy
April 8th 2025
Article

Combining durvalumab with chemotherapy produced a good safety profile without increasing surgical risk in the phase 2 iNDUCT-GETUG V08 trial.

Adjuvant Therapy and Post-Surgical Management Options for Kidney Cancer

Adjuvant Therapy and Post-Surgical Management Options for Kidney Cancer

Manojkumar Bupathi, MD, MS;Benjamin Garmezy, MD
April 1st 2025
Podcast

A recent Oncology Decoded podcast focuses on adjuvant therapy like pembrolizumab and optimal post-surgical care for patients with kidney cancer.

FDA Approves Nivolumab/Ipilimumab in Adult/Pediatric MSI-H or dMMR CRC

FDA Approves Nivolumab/Ipilimumab in Adult/Pediatric MSI-H or dMMR CRC

Tim Cortese
April 8th 2025
Article

The FDA approved nivolumab with ipilimumab in adult and pediatric patients with CRC based on data from the phase 3 CHECKMATE-8HW trial.

PENELOPE-B Trial Shows Mixed Palbociclib Results in Breast Cancer Subtypes

PENELOPE-B Trial Shows Mixed Palbociclib Results in Breast Cancer Subtypes

Tim Cortese
April 8th 2025
Article

Palbociclib with endocrine therapy did not improve outcomes in HR-positive, HER2-negative breast cancer, but improved invasive DFS in lobular disease.